Skip to main content

FDA recall, , Moderate risk

Daavlin Photera Phototherapy Devices

The Photera 400 phototherapy device has incorrect UV sensor gain.

What happened

Daavlin Distributing Company of Bryan, Ohio is recalling the Photera 600 3-D, Photera 400, and Photera 600 phototherapy devices because the calibrated output was not calculating correctly - UV Sensor GAIN being applied was incorrect - GAIN seemed to be "4/5" instead of "7" (counts were at ~1000 instead of ~5000). The recall began on March 5, 2026, and was added to the FDA's Enforcement Report on July 15, 2026, with US Nationwide distribution.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

3 products

Compare these details with yours, then check the recall notice to see which units are recalled.

  1. Photera 600 3-D, phototherapy device; Ultraviolet Lamp For Dermatologic Disorders

  2. Photera 400, phototherapy device; Ultraviolet Lamp For Dermatologic Disorders

  3. Photera 600, phototherapy device; Ultraviolet Lamp For Dermatologic Disorders

Recall details

Company began the recall
Sold in

US Nationwide distribution.

Company
Daavlin Distributing CompanyBryan, Ohio
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99331
Recall numbers
Z-2742-2026 to Z-2744-2026

All recalls from Daavlin Distributing Company

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)